Literature DB >> 22858443

Risk factors of viral hepatitis: yet to explore.

Seyed Hasan Bozorgi1, Homa Ramezani, Mehrdad Nooranipour, Mehrnoosh Ahmadi, Asgar Baghernejad, Azim Mostajeri, Hosein Kargar-Fard, Mohsen Sadri, Seyed Moayed Alavian.   

Abstract

BACKGROUND AND AIMS: The safety of donated blood is the most vital concern of a blood transfusion organization. Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) screening for blood transfusion products has gained more importance where knowing the prevalence rate will help health policy makers. In this paper, we will evaluate the prevalence of viral infection in donated blood in the province of Qazvin in 2009.
MATERIALS AND METHODS: This study has been conducted using a registration system of computerized records for donors in Qazvin in 2009 using the consensus mode on 20,591 blood donors. The results of their HBV, HCV, and HIV viral markers were evaluated and analyzed using the chi square statistical test.
RESULTS: The prevalence rate of HBV, HCV, and HIV viral markers using the ELISA primary test in the individuals studied has been 0.28%, 1.59% and 0.1%, respectively, and on the basis of their confirmatory tests, 0.23%, 0.17% and 0%, respectively. There was no significant statistical difference in their infection rate on the basis of sex and marital status. Regular donors (46.85%) had a smaller infection rate compared to others (P<0.005). There was a significant statistical difference in the rate of prevalence of infection for hepatitis B and C in the regular donors compared to first-time donors.
CONCLUSION: Considering the lower prevalence of viral markers in regular donors it is recommended that more use be made of them for blood donation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858443     DOI: 10.1016/j.transci.2012.06.023

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  7 in total

Review 1.  Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.

Authors:  Giovanna Vitaliti; Andrea Domenico Praticò; Carla Cimino; Giovanna Di Dio; Elena Lionetti; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 2.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman

Authors:  Majid Mohsenizadeh; Hamid Reza Mollaei; Motahareh Ghaziizadeh
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

4.  24 year outcomes of hepatitis B vaccination in Hangzhou, China.

Authors:  Jian Du; Yuyang Xu; Jun Wang; Shijun Liu; Yan Liu; Xiaoping Zhang; Erping Xu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Saeed Tajbakhsh; Marziyeh Gholizadeh Tangestani; Gholamreza Hajiani; Nasrin Sharifi; Sakineh Taherkhani; Abdolreza Nejadbolkheyr
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 6.  The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.

Authors:  Sarwat Mahmud; Vajiheh Akbarzadeh; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

Review 7.  The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Mehran Babanejad; Neda Izadi; Farid Najafi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-26       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.